QUADRIA INVESTS RS 850 CR IN DIALYSIS PROVIDER, NEPHROPLUS

NEW DELHI: Quadria Capital, a healthcare-focused PE firm, announced an investment of $102 million (Rs 850 crore) in NephroPlus, Asia’s largest dialysis network. Quadria will acquire a significant minority stake through a combination of a primary investment and the purchase of shares from existing shareholders, says a company statement.

The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia.

Founded in 2010, NephroPlus is a dialysis provider operating in sizeable, highgrowth markets across Asia with dominant leadership in India and a fast-growing footprint in the Philippines and other Asian countries.

Demand for dialysis services in the company’s target markets is expected to grow at a rate of over 11% annually over the next five years.

Vikram Vuppala, founder and CEO of NephroPlus, said: "Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients. We look forward to expanding in India, our core market, while exploring further opportunities to bring our expertise and clinical excellence to more patients in other global markets".

Sunil Thakur, Partner and head of South Asia at Quadria Capital, said: "Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. NephroPlus has demonstrated its ability to significantly improve health outcomes for its patients, whilst maintaining industry-leading growth and profitability."